Open AccessSingle dose of empagliflozin increases in vivo cardiac energy status in diabetic db/db mice
Author(s) -
Desiree Abdurrachim,
Emmy Manders,
Klaas Nicolay,
Eric Mayoux,
Jeanine J. Prompers
Publication year - 2018
Publication title -
cardiovascular research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.774
H-Index - 219
eISSN - 1755-3245
pISSN - 0008-6363
DOI - 10.1093/cvr/cvy246
Subject(s) - empagliflozin , in vivo , medicine , diabetes mellitus , diabetic cardiomyopathy , benzhydryl compounds , cardiology , pharmacology , type 2 diabetes , endocrinology , materials science , heart failure , biology , cardiomyopathy , microbiology and biotechnology , bisphenol a , composite material , epoxy
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom